Literature DB >> 19554599

Structure-property relationships of a class of carbamate-based fatty acid amide hydrolase (FAAH) inhibitors: chemical and biological stability.

Federica Vacondio1, Claudia Silva, Alessio Lodola, Alessandro Fioni, Silvia Rivara, Andrea Duranti, Andrea Tontini, Silvano Sanchini, Jason R Clapper, Daniele Piomelli, Marco Mor, Giorgio Tarzia.   

Abstract

Cyclohexylcarbamic acid aryl esters are a class of fatty acid amide hydrolase (FAAH) inhibitors, which includes the reference compound URB597. The reactivity of their carbamate fragment is involved in pharmacological activity and may affect their pharmacokinetic and toxicological properties. We conducted in vitro stability experiments in chemical and biological environments to investigate the structure-stability relationships in this class of compounds. The results show that electrophilicity of the carbamate influences chemical stability, as suggested by the relation between the rate constant of alkaline hydrolysis (log k(pH9)) and the energy of the lowest unoccupied molecular orbital (LUMO). Introduction of small electron-donor substituents at conjugated positions of the O-aryl moiety increased the overall hydrolytic stability of the carbamate group without affecting FAAH inhibitory potency, whereas peripheral non-conjugated hydrophilic groups, which favor FAAH recognition, helped decrease oxidative metabolism in the liver.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19554599      PMCID: PMC3517974          DOI: 10.1002/cmdc.200900120

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  48 in total

1.  Parametrization of electrophilicity for the prediction of the toxicity of aromatic compounds.

Authors:  M T Cronin; N Manga; J R Seward; G D Sinks; T W Schultz
Journal:  Chem Res Toxicol       Date:  2001-11       Impact factor: 3.739

2.  Modulation of anxiety through blockade of anandamide hydrolysis.

Authors:  Satish Kathuria; Silvana Gaetani; Darren Fegley; Fernando Valiño; Andrea Duranti; Andrea Tontini; Marco Mor; Giorgio Tarzia; Giovanna La Rana; Antonio Calignano; Arcangela Giustino; Maria Tattoli; Maura Palmery; Vincenzo Cuomo; Daniele Piomelli
Journal:  Nat Med       Date:  2002-12-02       Impact factor: 53.440

3.  Electrophilicity index as a possible descriptor of biological activity.

Authors:  R Parthasarathi; V Subramanian; D R Roy; P K Chattaraj
Journal:  Bioorg Med Chem       Date:  2004-11-01       Impact factor: 3.641

Review 4.  Discovery and development of fatty acid amide hydrolase (FAAH) inhibitors.

Authors:  Mark Seierstad; J Guy Breitenbucher
Journal:  J Med Chem       Date:  2008-12-11       Impact factor: 7.446

5.  Fatty acid amide hydrolase substrate specificity.

Authors:  D L Boger; R A Fecik; J E Patterson; H Miyauchi; M P Patricelli; B F Cravatt
Journal:  Bioorg Med Chem Lett       Date:  2000-12-04       Impact factor: 2.823

6.  Evidence for distinct roles in catalysis for residues of the serine-serine-lysine catalytic triad of fatty acid amide hydrolase.

Authors:  Michele K McKinney; Benjamin F Cravatt
Journal:  J Biol Chem       Date:  2003-05-06       Impact factor: 5.157

7.  Design, synthesis, and structure-activity relationships of alkylcarbamic acid aryl esters, a new class of fatty acid amide hydrolase inhibitors.

Authors:  Giorgio Tarzia; Andrea Duranti; Andrea Tontini; Giovanni Piersanti; Marco Mor; Silvia Rivara; Pier Vincenzo Plazzi; Chris Park; Satish Kathuria; Daniele Piomelli
Journal:  J Med Chem       Date:  2003-06-05       Impact factor: 7.446

8.  Cyclohexylcarbamic acid 3'- or 4'-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies.

Authors:  Marco Mor; Silvia Rivara; Alessio Lodola; Pier Vincenzo Plazzi; Giorgio Tarzia; Andrea Duranti; Andrea Tontini; Giovanni Piersanti; Satish Kathuria; Daniele Piomelli
Journal:  J Med Chem       Date:  2004-10-07       Impact factor: 7.446

9.  Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension.

Authors:  Sándor Bátkai; Pál Pacher; Douglas Osei-Hyiaman; Svetlana Radaeva; Jie Liu; Judith Harvey-White; László Offertáler; Ken Mackie; M Audrey Rudd; Richard D Bukoski; George Kunos
Journal:  Circulation       Date:  2004-09-27       Impact factor: 29.690

10.  Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha.

Authors:  Jin Fu; Silvana Gaetani; Fariba Oveisi; Jesse Lo Verme; Antonia Serrano; Fernando Rodríguez De Fonseca; Anja Rosengarth; Hartmut Luecke; Barbara Di Giacomo; Giorgio Tarzia; Daniele Piomelli
Journal:  Nature       Date:  2003-09-04       Impact factor: 49.962

View more
  13 in total

1.  Mechanistic studies of the inactivation of TEM-1 and P99 by NXL104, a novel non-beta-lactam beta-lactamase inhibitor.

Authors:  Thérèse Stachyra; Marie-Claude Péchereau; Jean-Michel Bruneau; Monique Claudon; Jean-Marie Frère; Christine Miossec; Kenneth Coleman; Michael T Black
Journal:  Antimicrob Agents Chemother       Date:  2010-10-04       Impact factor: 5.191

2.  A second generation of carbamate-based fatty acid amide hydrolase inhibitors with improved activity in vivo.

Authors:  Jason R Clapper; Federica Vacondio; Alvin R King; Andrea Duranti; Andrea Tontini; Claudia Silva; Silvano Sanchini; Giorgio Tarzia; Marco Mor; Daniele Piomelli
Journal:  ChemMedChem       Date:  2009-09       Impact factor: 3.466

3.  Biphenyl-3-yl alkylcarbamates as fatty acid amide hydrolase (FAAH) inhibitors: steric effects of N-alkyl chain on rat plasma and liver stability.

Authors:  Federica Vacondio; Claudia Silva; Alessio Lodola; Caterina Carmi; Silvia Rivara; Andrea Duranti; Andrea Tontini; Silvano Sanchini; Jason R Clapper; Daniele Piomelli; Giorgio Tarzia; Marco Mor
Journal:  Eur J Med Chem       Date:  2011-07-21       Impact factor: 6.514

4.  O-(triazolyl)methyl carbamates as a novel and potent class of fatty acid amide hydrolase (FAAH) inhibitors.

Authors:  Giampiero Colombano; Clara Albani; Giuliana Ottonello; Alison Ribeiro; Rita Scarpelli; Glauco Tarozzo; Jennifer Daglian; Kwang-Mook Jung; Daniele Piomelli; Tiziano Bandiera
Journal:  ChemMedChem       Date:  2014-10-22       Impact factor: 3.466

5.  Synthesis and structure-activity relationship studies of O-biphenyl-3-yl carbamates as peripherally restricted fatty acid amide hydrolase inhibitors.

Authors:  Guillermo Moreno-Sanz; Andrea Duranti; Laurin Melzig; Claudio Fiorelli; Gian Filippo Ruda; Giampiero Colombano; Paola Mestichelli; Silvano Sanchini; Andrea Tontini; Marco Mor; Tiziano Bandiera; Rita Scarpelli; Giorgio Tarzia; Daniele Piomelli
Journal:  J Med Chem       Date:  2013-07-03       Impact factor: 7.446

6.  Crystal structure of fatty acid amide hydrolase bound to the carbamate inhibitor URB597: discovery of a deacylating water molecule and insight into enzyme inactivation.

Authors:  Mauro Mileni; Satwik Kamtekar; David C Wood; Timothy E Benson; Benjamin F Cravatt; Raymond C Stevens
Journal:  J Mol Biol       Date:  2010-05-21       Impact factor: 5.469

7.  Approximating protein flexibility through dynamic pharmacophore models: application to fatty acid amide hydrolase (FAAH).

Authors:  Anna L Bowman; Alexandros Makriyannis
Journal:  J Chem Inf Model       Date:  2011-12-07       Impact factor: 4.956

8.  Identification and characterization of carprofen as a multitarget fatty acid amide hydrolase/cyclooxygenase inhibitor.

Authors:  Angelo D Favia; Damien Habrant; Rita Scarpelli; Marco Migliore; Clara Albani; Sine Mandrup Bertozzi; Mauro Dionisi; Glauco Tarozzo; Daniele Piomelli; Andrea Cavalli; Marco De Vivo
Journal:  J Med Chem       Date:  2012-10-08       Impact factor: 7.446

9.  Aryl N-[ω-(6-Fluoroindol-1-yl)alkyl]carbamates as Inhibitors of Fatty Acid Amide Hydrolase, Monoacylglycerol Lipase, and Butyrylcholinesterase: Structure-Activity Relationships and Hydrolytic Stability.

Authors:  Stefan Rudolph; Helmut Dahlhaus; Walburga Hanekamp; Christian Albers; Maximilian Barth; Giulia Michels; Denise Friedrich; Matthias Lehr
Journal:  ACS Omega       Date:  2021-05-14

10.  Design and synthesis of potent N-acylethanolamine-hydrolyzing acid amidase (NAAA) inhibitor as anti-inflammatory compounds.

Authors:  Yuhang Li; Longhe Yang; Ling Chen; Chenggang Zhu; Rui Huang; Xiao Zheng; Yan Qiu; Jin Fu
Journal:  PLoS One       Date:  2012-08-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.